Document is current
Any future updates will be listed below
-
Authors
Flynn, Sean M. http://orcid.org/0000-0001-7326-2659
Dhir, Somdutta http://orcid.org/0000-0002-6410-8702
Herka, Krzysztof http://orcid.org/0000-0001-7033-9091
Doyle, Colm
Melidis, Larry
Simeone, Angela
Hui, Winnie W. I.
Araujo Tavares, Rafael de Cesaris
Schoenfelder, Stefan http://orcid.org/0000-0002-3200-8133
Tannahill, David http://orcid.org/0000-0002-3811-6864
Balasubramanian, Shankar http://orcid.org/0000-0002-0281-5815
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 25 August 2024
First Online: 3 September 2024
Declarations
:
: Work with hESCs was authorized by the Steering Committee for the UK Stem Cell Bank and for Use of Stem Cells (MRC).
: Not applicable.
: S.B. is a founder and shareholder of Biomodal Ltd, GenomeTx, and RNAvate Ltd. L.M. is a consultant for Inflex Ltd. S.S. is a co-founder and shareholder of Enhanc3D Genomics Ltd.
